|
Michael G. Sension, MD Medical Director CAN Community Health Internal Medicine Ft. Lauderdale, FL |
Target Audience
This activity has been designed to meet the educational needs of physicians, physician assistants, advanced practice nurses and other health care professionals involved in the care of patients with HIV infection. It is tuition-free and there are no prerequisites.
Learning Objectives
Upon completion of the activity, participants should be better able to:
· Describe the impact of co-morbid conditions, including those associated with aging, HIV and ART, on patients with HIV infection
· Compare and contrast major ARV guideline recommendations for managing patients with HIV and comorbid conditions and discuss the relative advantages and disadvantages of different approaches
· Apply in clinical practice multidisciplinary approaches for reducing the burden of complex co-morbid conditions in patients with HIV to prevent morbidity and mortality and addressing the issue of potential drug-drug interactions
· Provide optimal care to older patients with HIV infection, including the assessment and management of co-morbid conditions associated with an aging population
· Apply knowledge and skills for selecting and monitoring the most effective long-term ARV therapy for patients with co-morbid conditions
Joint Accreditation Statement:
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and ViralEd, Inc. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
A statement of credit will be issued only upon receipt of a completed activity evaluation form and will be emailed to you.
Disclosure of Conflicts of
Interest
Postgraduate
Institute for Medicine (PIM) requires instructors, planners, managers and other
individuals who are in a position to control the content of this activity to
disclose any real or apparent conflict of interest (COI) they may have as
related to the content of this activity. All identified COI are thoroughly
vetted and resolved according to PIM policy.
PIM is committed to providing its learners with high quality CME
activities and related materials that promote improvements or quality in healthcare
and not a specific proprietary business interest of a commercial interest.
The faculty reported the following financial relationships or relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity:
Graeme Moyle, MD, MB, BS:
• Consulting Fees: Gilead, ViiV Healthcare
• Fees for Non-CME/CE Services Received Directly from a Commercial Interest or their agents: Thera Technologies, Merck
Paul Sax, MD:
• Consulting Fees: AbbVie, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline/ViiV, Janssen, Merck
• Contacted Research: NIH, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline/ViiV, Merck
• Other (Editorial Boards): Medscape, UpToDate, Open Forum Infectious Diseases
Michael G. Sension, MD
• Fees for Non-CME/CE Services Received Directly from a Commercial Interest: Gilead, Janssen, ViiV
The
PIM and ViralEd planners and managers have nothing to disclose.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
